Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
<p>Abstract</p> <p>Background</p> <p>The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality data and a systematic literature review, we e...
Main Authors: | Ker Katharine, Kiriya Junko, Perel Pablo, Edwards Phil, Shakur Haleema, Roberts Ian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Emergency Medicine |
Online Access: | http://www.biomedcentral.com/1471-227X/12/3 |
Similar Items
-
Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation
by: Perel Pablo, et al.
Published: (2010-02-01) -
Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial
by: Roberts, I, et al.
Published: (2012) -
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients
by: Ian Roberts, et al.
Published: (2023-02-01) -
A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
by: Abda Mahmood, et al.
Published: (2017-07-01) -
CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
by: Dewan Yashbir, et al.
Published: (2012-06-01)